Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Woodwork vs YourHealthRx

Woodwork
Graded #72

Higher grade

vs+3.6000000000000085
YourHealthRx
Graded #119

Lower grade

The verdict

Woodwork takes it — 73.2/100 to 69.6/100.

Woodwork grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Woodwork is a men's health telehealth platform built by Grindr that offers compounded GLP-1 weight-loss medications alongside ED care, with a focus on serving gay and queer men.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWoodwork +25
78
53
Dose & formulationEven
75
75
Clinical oversightYourHealthRx +5
82
87
Labs & monitoringWoodwork +7
74
67
FulfillmentYourHealthRx +28
66
94
Contract termsWoodwork +8
41
33
Woodwork · left barYourHealthRx · right bar

The numbers

MetricWoodworkYourHealthRx
WeighScore73.2/10069.6/100
GradeCC
Scorecard rank#72#119
Semaglutide$127/mo (starting dose, compounded)$170/mo (compounded)
Tirzepatide$199/mo (starting dose, compounded)$210/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Woodwork

Graded #72 · C

Strengths

  • Low transparent pricing: compounded semaglutide from $127/month, tirzepatide from $199/month, microdose $134/month
  • Compounded semaglutide offered as injection or oral tablet
  • No separate consult or membership fees
  • Free shipping, included lab work, and 1-on-1 care coaching
  • HSA and FSA eligible; bundles a free Grindr Unlimited subscription

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Cash-pay only — no insurance billing
  • States served are not listed publicly
  • No compounding pharmacy partner named and no LegitScript badge shown
  • Weight loss is secondary to the platform's men's-health/ED focus
YourHealthRx

Graded #119 · C

Strengths

  • Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
  • Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
  • Flat subscription price that doesn't change as your dose increases (no titration penalty)
  • Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
  • Transparent, education-first positioning with published medical disclaimer, privacy, and terms

Where it loses points

  • Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
  • Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard